Prescribing Trends of Oral Anticoagulants from 2010 to 2020 in Shanghai, China: A Retrospective Study

AIM: Non-vitamin K antagonist oral anticoagulants (NOACs) were developed as an alternative to warfarin to prevent thromboembolism in patients with atrial fibrillation (AF), prosthetic heart valves, venous thromboembolism (VTE), or other thrombotic disorders. The aim of this study is to explore the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chi, Wang, Jia, Yang, Ya, Ma, Er-Li, Lin, Hou-Wen, Liu, Bing-Long, Gu, Zhi-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Manuscript
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578173/
https://www.ncbi.nlm.nih.gov/pubmed/36250531
http://dx.doi.org/10.1177/10760296221132551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578173/
https://www.ncbi.nlm.nih.gov/pubmed/36250531
http://dx.doi.org/10.1177/10760296221132551

Ejemplares similares